Cite
MLA Citation
Claire Baker et al.. “Dose‐dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial.” Diabetes, obesity & metabolism, vol. 21, no. 11, 2019, pp. 2440–2449. http://access.bl.uk/ark:/81055/vdc_100092816652.0x000024